Dare Bioscience, Inc. Other Current Assets
Dare Bioscience, Inc. (DARE) had Other Current Assets of $456.43 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2026-08-13
- 2026-06-30: Other Assets, Current $456.43K.
- 2026-03-31: Other Assets, Current $687.76K.
- 2025-12-31: Other Assets, Current $573.06K.
- 2025-09-30: Other Assets, Current $53.16K.
| Period end | Other Assets, Current |
|---|---|
| 2026-06-30 | $456.43K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $687.76K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $573.06K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $53.16K 10-Q · filed 2025-11-13 |
| 2024-12-31 | $0.00 10-Q · filed 2025-11-13 |
| 2024-03-31 | $152.20K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $0.00 10-Q · filed 2024-05-14 |
| 2023-09-30 | $831.38K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $272.10K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $201.38K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $0.00 10-Q · filed 2023-11-09 |
| 2018-12-31 | $0.00 10-K · filed 2019-04-01 |
| 2017-12-31 | $193.50K 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |